Details about Tomas Philipson

Homepage:	http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp
Workplace:	Harris School of Public Policy, University of Chicago, (more information at EDIRC)

Access statistics for papers by Tomas Philipson.

Last updated 2009-09-17. Update your information in the RePEc Author Service.

Short-id: pph37

---

Jump to Journal Articles Chapters

Working Papers

2009

1. Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
   NBER Working Papers, National Bureau of Economic Research, Inc

2008

2. Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity
   NBER Working Papers, National Bureau of Economic Research, Inc View citations
3. The Value of Life in General Equilibrium
   NBER Working Papers, National Bureau of Economic Research, Inc View citations

2007

4. Integrated Insurance Design in the Presence of Multiple Medical Technologies
   NBER Working Papers, National Bureau of Economic Research, Inc View citations
   See also Journal Article in American Economic Review (2007)
5. Is the Food and Drug Administration Safe and Effective?
   NBER Working Papers, National Bureau of Economic Research, Inc
   See also Journal Article in Journal of Economic Perspectives (2008)
6. The Value of Life Near its End and Terminal Care
   NBER Working Papers, National Bureau of Economic Research, Inc
   Also in Levine's Working Paper Archive, David K. Levine (2007)

2006

7. Antitrust in the Not-For-Profit Sector
   NBER Working Papers, National Bureau of Economic Research, Inc View citations
   Also in NBER Working Papers, National Bureau of Economic Research, Inc (2001) View citations
   See also Journal Article in Journal of Law & Economics (2009)
8. Health Care, Technological Change, and Altruistic Consumption Externalities
   NBER Working Papers, National Bureau of Economic Research, Inc View citations
9. Intellectual Property and Marketing
   NBER Working Papers, National Bureau of Economic Research, Inc View citations
10. Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    Also in Public Economics, EconWPA (2005) View citations

2005

11. Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
12. Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc View citations

2004

13. Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    See also Chapter (2005)

2003

14. Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
15. The Quantity and Quality of Life and the Evolution of World Inequality
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    See also Journal Article in American Economic Review (2005)

2002

16. The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
17. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US
    Working Papers, Harris School of Public Policy Studies, University of Chicago View citations
18. The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (2002) View citations

2000

19. External Treatment Effects and Program Implementation Bias
    NBER Technical Working Papers, National Bureau of Economic Research, Inc View citations
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999)
20. Merit Motives and Government Intervention: Public Finance in Reverse
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations

1999

21. Aging and the Growth of Long-Term Care
    Working Papers, Harris School of Public Policy Studies, University of Chicago View citations
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1999) View citations
22. Economic Epidemiology and Infectious Diseases
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    See also Chapter (2000)
23. The Long-Run Growth in Obesity as a Function of Technological Change
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
    Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (1999) View citations

1998

24. Data MArkets and OPtimal Sample Size Determination
    DELTA Working Papers, DELTA (Ecole normale supérieure)
25. Nonprofit Production and Competition
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
26. Pricing and R&D with Related Margins
    DELTA Working Papers, DELTA (Ecole normale supérieure)
27. The Rise in Old Age Longevity and the Market for Long-Term Care
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1998) View citations
    See also Journal Article in American Economic Review (2002)

1997

28. An Empirical Examination of Information Barriers to Trade inInsurance
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996) View citations
    See also Journal Article in American Economic Review (1999)
29. Consumption vs. Production of Insurance
    NBER Working Papers, National Bureau of Economic Research, Inc
30. Health Investment Complementarities under Competing Risks
    Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra View citations
31. Observational Agency and Supply-Side Econometrics
    NBER Technical Working Papers, National Bureau of Economic Research, Inc
32. The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1997)

1996

33. Mortality Contingent Claims, Health Care, and Social Insurance
    University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State View citations
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996)
34. The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV
    Working Papers, Yale - Economic Growth Center View citations

1995

35. Death, Tetanus and Aerobics: The Evaluation of Disease-Specific Health Interventions
    CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations
    Also in Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra (1995)
36. Disease Complementarities and the Evaluation of Public Health Interventions
    NBER Working Papers, National Bureau of Economic Research, Inc View citations
37. Disease Eradication: Private vs. Public Vaccination
    DELTA Working Papers, DELTA (Ecole normale supérieure) View citations
38. Rational Epidemics and their Public Control
    DELTA Working Papers, DELTA (Ecole normale supérieure) View citations
    See also Journal Article in International Economic Review (1996)

1994

39. Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS
    Working Papers, Harris School of Public Policy Studies, University of Chicago
    Also in University of Chicago - Population Research Center, Chicago - Population Research Center View citations

Undated

40. Estimating the Extent of Trade Under Incomplete Information: The Case of HIV
    University of Chicago - Population Research Center, Chicago - Population Research Center
41. Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference
    University of Chicago - Population Research Center, Chicago - Population Research Center
42. Nonprofit Production
    University of Chicago - Population Research Center, Chicago - Population Research Center View citations
43. Self-Interested Treatment Evaluation in Experiments
    University of Chicago - Population Research Center, Chicago - Population Research Center

Journal Articles

2009

1. Antitrust in the Not-for-Profit Sector
   Journal of Law & Economics, 2009, 52, (1), 1-18
   See also Working Paper (2006)

2008

2. Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
   Journal of Public Economics, 2008, 92, (5-6), 1306-1325
3. Cost-effectiveness analysis and innovation
   Journal of Health Economics, 2008, 27, (5), 1224-1236
4. Is the Food And Drug Administration Safe And Effective?
   Journal of Economic Perspectives, 2008, 22, (1), 85-102
   See also Working Paper (2007)
5. Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy
   Journal of Economic Literature, 2008, 46, (4), 974-82

2007

6. Commentary
   Health Economics, 2007, 28, (4-5), 437-438
   Also in Health Economics, 2007, 28, (4-5), 467-468 (2007)
   Managerial and Decision Economics, 2007, 28, (4-5), 467-468 (2007)
   Health Economics, 2007, 28, (4-5), 453-454 (2007)
   Managerial and Decision Economics, 2007, 28, (4-5), 453-454 (2007)
   Managerial and Decision Economics, 2007, 28, (4-5), 437-438 (2007)
7. Integrated Insurance Design in the Presence of Multiple Medical Technologies
   American Economic Review, 2007, 97, (2), 427-432 View citations
   See also Working Paper (2007)
8. Labor Supply and Weight
   Journal of Human Resources, 2007, 42, (1) View citations
9. The institute of medicine report on the FDA: where is the science?
   Health Economics, 2007, 16, (3), 219-221

2006

10. The nonprofit sector and industry performance
    Journal of Public Economics, 2006, 90, (8-9), 1681-1698 View citations

2005

11. The Quantity and Quality of Life and the Evolution of World Inequality
    American Economic Review, 2005, 95, (1), 277-291 View citations
    See also Working Paper (2003)
12. Welfare-Enhancing Technological Change and the Growth of Obesity
    American Economic Review, 2005, 95, (2), 253-257 View citations

2002

13. Pricing and R&D When Consumption Affects Longevity
    RAND Journal of Economics, 2002, 33, (1), 85-95 View citations
14. The Rise in Old-Age Longevity and the Market for Long-Term Care
    American Economic Review, 2002, 92, (1), 295-306 View citations
    See also Working Paper (1998)

2001

15. Data Markets, Missing Data, and Incentive Pay
    Econometrica, 2001, 69, (4), 1099-1111 View citations
16. Managed Care and the Quality of Health Care: A Misguided Debate?
    Journal of Legal Studies, 2001, 30, (2), 753-58
17. The world-wide growth in obesity: an economic research agenda
    Health Economics, 2001, 10, (1), 1-7 View citations

1999

18. An Empirical Examination of Information Barriers to Trade in Insurance
    American Economic Review, 1999, 89, (4), 827-846 View citations
    See also Working Paper (1997)
19. Longevity Complementarities under Competing Risks
    American Economic Review, 1999, 89, (5), 1358-1371 View citations
20. Measurement errors: A principal investigator-agent approach
    Journal of Econometrics, 1999, 91, (2), 273-298 View citations

1998

21. Old-Age Longevity and Mortality-Contingent Claims
    Journal of Political Economy, 1998, 106, (3), 551-573 View citations
22. Subject Evaluation in Social Experiments
    Econometrica, 1998, 66, (2), 381-408 View citations

1997

23. Data Markets and the Production of Surveys
    Review of Economic Studies, 1997, 64, (1), 47-72 View citations
24. Disease Eradication: Private versus Public Vaccination
    American Economic Review, 1997, 87, (1), 222-30 View citations
25. Multiple-output agency incentives in data production: experimental evidence
    European Economic Review, 1997, 41, (3-5), 961-970
26. The evaluation of new health care technology: The labor economics of statistics
    Journal of Econometrics, 1997, 76, (1-2), 375-395

1996

27. An empirical examination of the implications of assortative matching on the incidence of HIV
    Journal of Health Economics, 1996, 15, (6), 735-749 View citations
28. Equilibrium and Efficiency in an Organized Vote Market
    Public Choice, 1996, 89, (3-4), 245-65 View citations
29. Rational Epidemics and Their Public Control
    International Economic Review, 1996, 37, (3), 603-24 View citations
    See also Working Paper (1995)
30. The Economic Epidemiology of Crime
    Journal of Law & Economics, 1996, 39, (2), 405-33 View citations

1995

31. A Theoretical and Empirical Investigation of the Effects of Public Health Subsidies for STD Testing
    The Quarterly Journal of Economics, 1995, 110, (2), 445-74 View citations
32. The welfare loss of disease and the theory of taxation
    Journal of Health Economics, 1995, 14, (3), 387-395 View citations

1994

33. Public Spending on AIDS Education: An Economic Analysis
    Journal of Law & Economics, 1994, 37, (1), 17-38 View citations

1993

34. Social Welfare and Measurement of Segregation
    Journal of Economic Theory, 1993, 60, (2), 322-334 View citations

1991

35. Dynamic information release
    Journal of Economics, 1991, 53, (2), 205-213

Chapters

2005

1. Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
   A chapter in Frontiers in Health Policy Research, Volume 8, 2005
   See also Working Paper (2004)

2003

2. Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation
   A chapter in The Governance of Not-for-Profit Organizations, 2003, pp 181-216 View citations

2001

3. Medical Care Output and Productivity in the Nonprofit Sector
   A chapter in Medical Care Output and Productivity, 2001, pp 119-140 View citations
4. Public Financing and the Market for Long-Term Care
   A chapter in Frontiers in Health Policy Research, Volume 4, 2001, pp 77-94

2000

5. Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?
   A chapter in The Changing Hospital Industry: Comparing For-Profit and Not-for-Profit Institutions, 2000, pp 325-356 View citations
6. Economic epidemiology and infectious diseases
   Chapter 33 in Handbook of Health Economics, 2000, vol. 1, pp 1761-1799 View citations
   See also Working Paper (1999)